-E G Hahn Researcher Activity Profile

Research Author Detailed Information 

E G Hahn Publication Rate By Year

E G Hahn has published 1 paper(s) in 1991, 1 paper(s) in 1993, 2 paper(s) in 2004, 4 paper(s) in 2005, 3 paper(s) in 2006, 27 paper(s) in 2007, 11 paper(s) in 2008, for a total of 49 research publications in total.

E G Eg Hahn Author Information

LAST NAME: hahn

FIRST NAME: E G

INITIALS: eg

AFFILIATION:

Papers

E G Hahn's Publication Record

1. Adiponectin, resistin and subclinical inflammation--the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity. Year Published: 2007
Medical Department I, Division of Endocrinology and Metabolism, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. igor.harsch@med1.imed.uni-erlangen.de
2. Duodenal mucosal protection by bicarbonate secretion and its mechanisms. Year Published: 2004
Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. mpkontur@cyf-kr.edu.pl
3. Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. Year Published: 2005
Department of Medicine, University Erlangen-Nuremberg, Germany. peter.konturek@med1.imed.uni-erlangen.de
4. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract. Year Published: 2005
Department of Medicine I, Gastroenterology, Functional Tissue Diagnostics, Erlangen University, Germany. Martin.Raithel@ med1.imed.uni-erlangen.de
5. Arthropathy and cutaneous manifestations in a 28-year-old patient with cystic fibrosis. Year Published: 2006
Medical Department 1, University of Erlangen-Nuremberg, Ulmenweg 18, D- 91054 Erlangen, Germany. Sabine.Lampert@med1.imed.uni-erlangen.de
6. Non-compliance in surveillance for patients with previous resection of large (>= 1 cm) colorectal adenomas. Year Published: 2006
Department of Medicine 1, University Hospital of Erlangen, Ulmenweg 18, 91054 Erlangen, Germany. wolfgang.brueckl@med1.imed.uni-erlangen.de.
7. Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. Year Published: 2007
First Department of Medicine, University Erlangen-Nuremberg, Germany. pkonturek@aol.com
8. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. Year Published: 2007
Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. mpbrzozo@cyf-kr.edu.pl
9. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin. Year Published: 2007
First Department of Medicine, University Erlangen-Nuremberg, Erlangen, Germany. pkonturek@web.de
10. Percutaneous radiofrequency ablation of liver tumors using multiple saline-perfused electrodes. Year Published: 2007
aDepartment of Medicine I, Friedrich-Alexander University, NOZ, Ulmenweg 18, 91054 Erlangen, Germany.
11. Follow-up after colorectal polypectomy: a benefit-risk analysis of German surveillance recommendations. Year Published: 2007
Department of Medical Biometry and Informatics, University of Heidelberg, 69120, Heidelberg, Germany. f.becker@gmx.ch
12. The combination of the histone-deacetylase inhibitor trichostatin A and gemcitabine induces inhibition of proliferation and increased apoptosis in pancreatic carcinoma cells. Year Published: 2007
Department of Medicine I, University Hospital Erlangen, Erlangen, Germany.
13. [Recurrent melena in a 75-year-old man with gastrointestinal stromal tumor] Year Published: 2007
14. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. Year Published: 2007
First Department of Medicine, University Erlangen-Nurenberg, Erlangen, Germany. peter.konturek@med1.imed.uni-erlangen.de.
15. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo. Year Published: 2007
Department of Medicine 1, University Hospital Erlangen, D-91054 Erlangen, Germany.
16. [An approach to individualised therapy of non-small cell ling carcinoma (NSCLC)--relevance of molecular predictive and prognostic factors] Year Published: 2007
17. Role of p-glycoprotein inhibition for drug interactions : evidence from in vitro and pharmacoepidemiological studies. Year Published: 2007
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg, Erlangen, GermanyDepartment of Pharmacy, University Hospital, Erlangen, Germany.
18. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo. Year Published: 2007
Department of Medicine 1, University Hospital Erlangen, D-91054, Erlangen, Germany.
19. Neural aspects of ghrelin-induced gastroprotection against mucosal injury induced by noxious agents. Year Published: 2007
Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. mpbrzozo@cyf-kr.edu.pl
20. A novel model for training in ERCP with double-balloon enteroscopy after abdominal surgery. Year Published: 2007
Department of Medicine I, University of Erlangen-Nuremberg, Erlangen, Germany. juergen.maiss@uk-erlangen.de
21. Prostaglandins as mediators of COX-2 derived carcinogenesis in gastrointestinal tract. Year Published: 2005
Department of Medicine, University Erlangen-Nuremberg, Germany. peter.konturek@med1.imed.uni-erlangen.de
22. Significance of salicylate intolerance in diseases of the lower gastrointestinal tract. Year Published: 2005
Department of Medicine I, Gastroenterology, Functional Tissue Diagnostics, Erlangen University, Germany. Martin.Raithel@ med1.imed.uni-erlangen.de
23. Percutaneous Ultrasound-Guided Radiofrequency Ablation (RFA) Using Saline-Perfused (Wet) Needle Electrodes for the Treatment of Hepatocellular Carcinoma - Long Term Experience. Year Published: 2007
24. Ascorbic acid attenuates aspirin-induced gastric damage: role of inducible nitric oxide synthase. Year Published: 2007
First Department of Medicine, University Erlangen-Nuremberg, Germany. pkonturek@aol.com
25. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin. Year Published: 2007
First Department of Medicine, University Erlangen-Nuremberg, Erlangen, Germany. pkonturek@web.de
26. Follow-up after colorectal polypectomy: a benefit-risk analysis of German surveillance recommendations. Year Published: 2007
Department of Medical Biometry and Informatics, University of Heidelberg, 69120, Heidelberg, Germany. f.becker@gmx.ch
27. Arthropathy and cutaneous manifestations in a 28-year-old patient with cystic fibrosis. Year Published: 2006
Medical Department 1, University of Erlangen-Nuremberg, Ulmenweg 18, D- 91054 Erlangen, Germany. Sabine.Lampert@med1.imed.uni-erlangen.de
28. Adiponectin, resistin and subclinical inflammation--the metabolic burden in Launois Bensaude Syndrome, a rare form of obesity. Year Published: 2007
Medical Department I, Division of Endocrinology and Metabolism, Friedrich-Alexander University of Erlangen-Nuremberg, Erlangen, Germany. igor.harsch@med1.imed.uni-erlangen.de
29. [Drug Therapy for Small-Cell Lung Cancer (SCLC) - New Molecular Strategies for Therapy.] Year Published: 2008
30. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo. Year Published: 2007
Department of Medicine 1, University Hospital Erlangen, D-91054, Erlangen, Germany.
31. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy] Year Published: 2008
32. Duodenal mucosal protection by bicarbonate secretion and its mechanisms. Year Published: 2004
Department of Physiology, Jagiellonian University Medical College, Cracow, Poland. mpkontur@cyf-kr.edu.pl
33. Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Year Published: 2008
34. A novel model for training in ERCP with double-balloon enteroscopy after abdominal surgery. Year Published: 2007
Department of Medicine I, University of Erlangen-Nuremberg, Erlangen, Germany. juergen.maiss@uk-erlangen.de
35. Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Year Published: 2007
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg, Erlangen, Germany.
36. [Drug therapy for small-cell lung cancer (SCLC)--new molecular strategies for therapy] Year Published: 2008
Medizinische Klinik 1, Universitätsklinikum Erlangen. wolfgang.brueckl@uk-erlangen.de
37. Early detection of premalignant conditions in the colon by fluorescence endoscopy using local sensitization with hexaminolevulinate. Year Published: 2008
Department of Medicine II, Hospital Munich-Pasing, Teaching Hospital of University of Munich (LMU), Munich, Germany. brigitte.mayinger@krankenhaus-pasing.de
38. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience. Year Published: 2007
Medicine I, University Erlangen-Nürnberg, Erlangen. dr.j.haensler@t-online.de
39. Early detection of premalignant conditions in the colon by fluorescence endoscopy using local sensitization with hexaminolevulinate. Year Published: 2008
Department of Medicine II, Hospital Munich-Pasing, Teaching Hospital of University of Munich (LMU), Munich, Germany. brigitte.mayinger@krankenhaus-pasing.de
40. [54-year-old patient with dysphagia] Year Published: 1991
41. [Laser lithotripsy in the treatment of bile duct calculi] Year Published: 1993
Medizinische Klinik I mit Poliklinik, Friedrich-Alexander-Universität, Erlangen-Nürnberg.
42. Benefit-risk analysis of different risk-related surveillance schedules following colorectal polypectomy. Year Published: 2008
Department of Medical Biometry and Informatics, University of Heidelberg, Heidelberg, Germany.
43. Effect of CPAP on insulin resistance in patients with obstructive sleep apnoea and type 2 diabetes. Year Published: 2008
Dr I A Harsch, Department of Medicine I, Friedrich-Alexander University Erlangen-Nuremberg, Ulmenweg 18, 91054 Erlangen, Germany; igor.harsch@uk-erlangen.de.
44. Decreased histamine catabolism in the colonic mucosa of patients with colonic adenoma. Year Published: 2008
45. Effect of CPAP on insulin resistance in patients with obstructive sleep apnoea and type 2 diabetes. Year Published: 2008
46. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins. Year Published: 2007
First Department of Medicine, University Erlangen-Nurenberg, Erlangen, Germany. peter.konturek@med1.imed.uni-erlangen.de
47. Percutaneous ultrasound-guided radiofrequency ablation (RFA) using saline-perfused (wet) needle electrodes for the treatment of hepatocellular carcinoma--long term experience. Year Published: 2007
48. Hepatic transit time in benign liver lesions. Year Published: 2008
Medicine 1, University of Erlangen Nuremberg.
49. Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studies. Year Published: 2007
Institute of Experimental and Clinical Pharmacology and Toxicology, University of Erlangen-Nuremberg, Erlangen, Germany.